Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Robert, Wenham"'
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100754- (2021)
Stage IIIC is the most common stage of locally advanced sub-stage of endometrial cancer, nevertheless, the optimal management for these patients remains controversial. Adjuvant chemotherapy alone more effectively suppressed distant metastases but res
Externí odkaz:
https://doaj.org/article/4ce00757bcef4ffe83de019d047c377b
Publikováno v:
Journal of Gynecologic Surgery. 39:49-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65d19ba640ec864b252e5718ac536091
https://doi.org/10.1089/gyn.2022.0081
https://doi.org/10.1089/gyn.2022.0081
Autor:
Maximilian Strobl, Alexandra L. Martin, Jeffrey West, Jill Gallaher, Mark Robertson-Tessi, Robert Gatenby, Robert Wenham, Philip Maini, Mehdi Damaghi, Alexander Anderson
Publikováno v:
bioRxiv
Toxicity and emerging drug resistance are important challenges in PARP inhibitor (PARPi) treatment of ovarian cancer. Recent research has shown that evolutionary-inspired treatment algorithms which adapt treatment to the tumor’s treatment response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d68267af23860d6915841b0caa12f1
https://europepmc.org/articles/PMC10055330/
https://europepmc.org/articles/PMC10055330/
Autor:
Robert Wenham, Sharad Ghamande, Vicky Makker, June Hou, Linda Duska, Daniela Matei, Manali Bhave, Rachael Scott, Natalyn Hawk, Tingting Song, Deborah K. Armstrong
Publikováno v:
Cancer Research. 83:CT056-CT056
Background: MORAb-202 (farletuzumab ecteribulin) is an antibody-drug conjugate (ADC) comprised of the humanized antifolate receptor-alpha (FRα) monoclonal antibody, farletuzumab, and the cytotoxic microtubule inhibitor, eribulin, conjugated by a cat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0c8c71b5f01598e0f031422c24e8d5d
https://doi.org/10.1158/1538-7445.am2023-ct056
https://doi.org/10.1158/1538-7445.am2023-ct056
Autor:
Robert Wenham, Marco Davila, Daniel Abate-Daga, Melissa McGettigan, Xuefeng Wang, Theresa Boyle, Pamela Garzone, Amit Kumar, Jose Conejo-Garcia
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bd7e853b174e87eaa96f4daf855865d
https://doi.org/10.1136/jitc-2022-sitc2022.0672
https://doi.org/10.1136/jitc-2022-sitc2022.0672
Autor:
Eugenia Girda, Emese Zsiros, John Nakayama, Sarah Whelan, Srinand Nandakumar, Seema Rogers, Beverly Benson, Michael Lotze, Robert Brown, Robert Wenham
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::713c6106f7f2df4a57a9104d0d82cf2e
https://doi.org/10.1136/jitc-2022-sitc2022.0671
https://doi.org/10.1136/jitc-2022-sitc2022.0671
Autor:
Robert Wenham, Sharad Ghamande, Vicky Makker, June Hou, Linda Duska, Daniela Matei, Manali Bhave, Rachael Scott, Natalyn Hawk, Tingting Song, Deborah K Armstrong
Publikováno v:
Ovarian cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98a5a18ef05e563abcc1ad0d84ffe8c5
https://doi.org/10.1136/ijgc-2022-esgo.667
https://doi.org/10.1136/ijgc-2022-esgo.667
Autor:
John K, Chan, Chunqiao, Tian, Joshua P, Kesterson, Bradley J, Monk, Daniel S, Kapp, Brittany, Davidson, Sharon, Robertson, Larry J, Copeland, Joan L, Walker, Robert, Wenham, Yovanni, Casablanca, Nick M, Spirtos, Krishnansu S, Tewari, Jeffery G, Bell
Publikováno v:
Obstetrics and gynecology. 139(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d2cda1b23694a04fc904a3be1780ff2
https://pubmed.ncbi.nlm.nih.gov/35675622
https://pubmed.ncbi.nlm.nih.gov/35675622
Autor:
Sarah Adams, Carolyn Muller, David O’Malley, Kari Ring, Robert Wenham, Karen Finkelstein, Teresa Rutledge, Elizabeth Lokich, Xavier Paliard, Olivier Rixe, Ichiko Kinjyo, Steven Eberhardt, Ji-Hyun Lee, Phyllis Gimotty
Publikováno v:
Gynecologic Oncology. 166:S60-S61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbab2655aa34099daa29b627551a1e7c
https://doi.org/10.1016/s0090-8258(22)01315-4
https://doi.org/10.1016/s0090-8258(22)01315-4
Autor:
Maximilian Strobl, Mehdi Damaghi, Alexandra Martin, Samantha Byrne, Mark Robertson-Tessi, Robert Gatenby, Robert Wenham, Philip Maini, Alexander R.A. Anderson
Publikováno v:
Cancer Research. 82:B009-B009
PARP inhibitors (PARPis) represent a great advancement in the treatment of ovarian cancer, yet these drugs often fail after a few months due to emerging drug resistance. A recent clinical trial in prostate cancer showed that evolutionary-inspired, ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::718bab8b60c6a8fc99dc901d92c3506c
https://doi.org/10.1158/1538-7445.evodyn22-b009
https://doi.org/10.1158/1538-7445.evodyn22-b009